SOBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
South Bow Corp (SOBO) does not present a compelling buy opportunity for a beginner, long-term investor at this moment. While the company has demonstrated strong net income and EPS growth in the latest quarter, the declining revenue and gross margin raise concerns about its overall growth trajectory. Additionally, the lack of significant positive trading trends, neutral analyst ratings, and absence of recent news catalysts suggest limited upside potential in the near term. The technical indicators show bullish momentum, but the overbought RSI and lack of strong proprietary trading signals further support a cautious stance.
The technical indicators for SOBO show bullish momentum with SMA_5 > SMA_20 > SMA_200 and MACD above 0. However, the RSI of 73.548 indicates the stock is approaching overbought territory. Key resistance levels are at 32.653 and 33.59, with support at 31.137 and 29.62. The stock is trading near its resistance, suggesting limited short-term upside.
Strong net income growth (+54.72% YoY) and EPS growth (+55.17% YoY) in the latest quarter. Analysts highlight tailwinds from strong power demand and LNG exports, which may support long-term opportunities.
Revenue declined by -13.62% YoY, and gross margin dropped by -14.13% YoY in the latest quarter. Analysts express concerns about single-asset EBITDA concentration, operational execution risks, and elevated leverage. No recent news or significant trading trends to drive momentum.
In Q3 2025, South Bow Corp's revenue dropped by -13.62% YoY to $461M, while net income increased by 54.72% YoY to $93M. EPS rose by 55.17% YoY to 0.45, but gross margin declined by -14.13% YoY to 32.32%.
Analyst sentiment is neutral overall. Scotiabank raised its price target to $30, citing long-term tailwinds but maintained a Sector Perform rating. UBS initiated coverage with a Neutral rating and a C$39 price target, highlighting an attractive dividend yield but limited growth potential. Barclays initiated coverage with an Equal Weight rating and a $27 price target, noting risks such as single-asset EBITDA concentration and elevated leverage.
